These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9299979)

  • 1. Factor X values as a means to assess the extent of oral anticoagulation in patients receiving antithrombin drugs.
    Hoppensteadt DA; Kahn S; Fareed J
    Clin Chem; 1997 Sep; 43(9):1786-8. PubMed ID: 9299979
    [No Abstract]   [Full Text] [Related]  

  • 2. Argatroban, a new treatment option for heparin-induced thrombocytopenia.
    Cleveland KW
    Crit Care Nurse; 2003 Dec; 23(6):61-6. PubMed ID: 14692173
    [No Abstract]   [Full Text] [Related]  

  • 3. Heparin-induced thrombocytopenia: what clinicians need to know.
    Chong BH; Isaacs A
    Thromb Haemost; 2009 Feb; 101(2):279-83. PubMed ID: 19190810
    [No Abstract]   [Full Text] [Related]  

  • 4. Heparin-Induced Thrombocytopenia in Infants after Heart Surgery.
    Abdillah JN; Hu Q; Chen X; Chen X; Zhou W; Luo W; Huang L
    Thorac Cardiovasc Surg; 2019 Jan; 67(1):21-27. PubMed ID: 29605959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulation in children: Making the most of little patients and little evidence.
    Young G; Male C; van Ommen CH
    Blood Cells Mol Dis; 2017 Sep; 67():48-53. PubMed ID: 28552476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin-induced thrombocytopenia and cardiopulmonary bypass: perioperative argatroban use.
    Lubenow N; Selleng S; Wollert HG; Eichler P; Müllejans B; Greinacher A
    Ann Thorac Surg; 2003 Feb; 75(2):577-9. PubMed ID: 12607680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coagulation laboratory testing in patients treated with argatroban.
    Walenga JM; Fasanella AR; Iqbal O; Hoppensteadt DA; Ahmad S; Wallis DE; Bakhos M
    Semin Thromb Hemost; 1999; 25 Suppl 1():61-6. PubMed ID: 10357154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticoagulation with Novastan (argatroban) in patients with heparin-induced thrombocytopenia and heparin-induced thrombocytopenia and thrombosis syndrome.
    Lewis BE; Walenga JM; Wallis DE
    Semin Thromb Hemost; 1997; 23(2):197-202. PubMed ID: 9200347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Standardization of laboratory tests for controlling anticoagulent therapy.
    Zucker S; Cathey MH; Sox PJ; Hall EC
    Am J Clin Pathol; 1970 Mar; 53(3):348-54. PubMed ID: 5416772
    [No Abstract]   [Full Text] [Related]  

  • 10. An overview of heparin-induced thrombocytopenia.
    Donovan JL; Tran MT; Kanaan AO
    J Pharm Pract; 2010 Jun; 23(3):226-34. PubMed ID: 21507818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical utility of anti-Xa monitoring and differential sensitivity of prothrombin time assays: an illustrated case report.
    Than H; Loh JB; Sum CL; Ng HJ
    J Clin Pathol; 2015 Apr; 68(4):318-9. PubMed ID: 25688138
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical evaluation of MD-805].
    Matsuo T
    Rinsho Byori; 1987 Sep; Spec No 73():150-60. PubMed ID: 3437530
    [No Abstract]   [Full Text] [Related]  

  • 13. Transition to an oral anticoagulant in patients with heparin-induced thrombocytopenia.
    Bartholomew JR
    Chest; 2005 Feb; 127(2 Suppl):27S-34S. PubMed ID: 15706028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Argatroban in adult extracorporeal membrane oxygenation.
    Johnston N; Wait M; Huber L
    J Extra Corpor Technol; 2002 Dec; 34(4):281-4. PubMed ID: 12533066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Argatroban anticoagulation in patients with heparin-induced thrombocytopenia.
    Lewis BE; Wallis DE; Leya F; Hursting MJ; Kelton JG;
    Arch Intern Med; 2003 Aug 11-25; 163(15):1849-56. PubMed ID: 12912723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimal Prolongation of Prothrombin Time with Extended Exposure to Argatroban.
    McAlister RK; Ito S
    Pharmacotherapy; 2015 Jul; 35(7):e122-6. PubMed ID: 26147471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombelastography in a patient with heparin-induced thrombocytopenia treated with argatroban.
    Zayac EA; Pivalizza EG; Levine RL
    Anesth Analg; 2008 Jan; 106(1):351-2. PubMed ID: 18165611
    [No Abstract]   [Full Text] [Related]  

  • 18. The first report of successful carotid stent implant using argatroban anticoagulation in a patient with heparin-induced thrombocytopenia and thrombosis syndrome: a case report.
    Lewis BE; Rangel Y; Fareed J
    Angiology; 1998 Jan; 49(1):61-7. PubMed ID: 9456166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of the chromogenic factor X assay in patients transitioning from argatroban to warfarin therapy.
    Austin JH; Stearns CR; Winkler AM; Paciullo CA
    Pharmacotherapy; 2012 Jun; 32(6):493-501. PubMed ID: 22511112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Argatroban, bivalirudin, and lepirudin do not decrease clot propagation and strength as effectively as heparin-activated antithrombin in vitro.
    Nielsen VG; Steenwyk BL; Gurley WQ; Pereira SJ; Lell WA; Kirklin JK
    J Heart Lung Transplant; 2006 Jun; 25(6):653-63. PubMed ID: 16730571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.